COMMUNIQUÉS West-GlobeNewswire

Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
12/03/2018
SAN CARLOS, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Adherium’s Directors Purchase Approximately 1.4 Million Shares on the Open Market
12/03/2018
SAN MATEO, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced that members of its Board of Directors recently [...]
IntelGenx Clarifies Recent Preliminary 2018 Proxy Statement Filing
12/03/2018
SAINT LAURENT, Quebec, March 12, 2018 (GLOBE NEWSWIRE) -- In response to investor inquiries received about its preliminary proxy statement, filed with the U.S. Securities and Exchange Commission on March 7, 2018, [...]
Kiadis Pharma N. V.: CORRECTION (Includes Disclaimers) Kiadis Pharma launches a private placement of approximately 2.6 million new shares
12/03/2018
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release, publication or distribution [...]
Kiadis Pharma N. V.: Kiadis Pharma launches a private placement of approximately 2.6 million new shares
12/03/2018
Kiadis Pharma launches a private placement of approximately 2.6 million new shares Amsterdam, The Netherlands, March 12, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS [...]
Annual General Meeting in ALK-Abelló A/S held on 12 March 2018
12/03/2018
Copenhagen, 2018-03-12 17:22 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) held its annual general meeting on 12 March 2018. The annual general meeting transacted the following business: Adoption [...]
Portola Pharmaceuticals Announces New Interim Results from Ongoing ANNEXA-4 Study of Factor Xa Inhibitor Reversal Agent AndexXa® (Andexanet Alfa) in Patients with Life-Threatening Bleeding
12/03/2018
– Excellent or Good Hemostasis Achieved in 83 Percent of Patients; Thrombotic Events Consistent with High Background Thrombotic Risk – – Data Presented in Late-Breaking Clinical Trial Session at American College of [...]
UPDATE -- Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County
12/03/2018
MIAMI, March 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has executed a letter of intent to purchase a pharmacy in Palm Beach County. [...]
Ossur Hf : Transactions in relation to share buyback program
12/03/2018
Announcement no. 20/2018 Reykjavik, 12 March 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
Shire plc : Elections for the interim dividend in respect of the six months to December 31, 2017
12/03/2018
Elections for the interim dividend in respect of the six months to December 31, 2017 March 12, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announced on February 14, 2018, an interim dividend of 29.79 US [...]
Shire plc : Director/PDMR Shareholding
12/03/2018
Director/PDMR Shareholding March 12, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Orphazyme Annual Report 2017 Presentation
12/03/2018
Orphazyme A/S Investor news No. 05/2018 Copenhagen, March 12, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that the [...]
Progressive Care CEO, S. Parikh Mars, Joins Everett Jolly on Uptick Newswire's "Stock Day" Podcast
12/03/2018
Phoenix, March 12, 2018 (GLOBE NEWSWIRE) -- Phoenix, AZ – March 13, 2018 – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a healthcare services and technology company, joins Uptick Newswire to discuss recent [...]
Medifirst Solutions Announces an Update for China Distribution
12/03/2018
FREEHOLD, NJ, March 12, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]
Notification about deal with property
12/03/2018
Latvia, 2018-03-12 15:34 CET (GLOBE NEWSWIRE) -- AS ”Latvijas Jūras medicīnas centrs” informs that it has sold property in Vecmīgrāvis 5. līnija 26. The deal is finished on 06 March, 2018. and AS ”Latvijas Jūras [...]
Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes
12/03/2018
'Smart' CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management DUBLIN - March 12, 2018 - Medtronic plc ( [...]
Chris Bunka, CEO of Lexaria Bioscience Corp., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Discuss New Products and Company Evolution
12/03/2018
Phoenix, March 12, 2018 (GLOBE NEWSWIRE) -- Phoenix, AZ – March 13, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, today announced CEO, Chris [...]
PCI Biotech to present at Bio-Europe Spring 2018
12/03/2018
Oslo, Norway, March 12, 2018 PCI Biotech (OSE: PCIB ), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at Bio-Europe Spring [...]
Surgery Partners Announces Appointment of Thomas F. Cowhey as Chief Financial Officer
12/03/2018
NASHVILLE, Tenn., March 12, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) (the “Company”), a leading healthcare services company, today announced that Thomas F. Cowhey has been appointed Executive Vice [...]

Pages